Our findings showed that the total expression of RIP3 was unchanged in the lungs of both stages of PAH; however, its active phosphorylated form pThr231/Ser232‐RIP3, serving as an upstream molecule of MLKL,8 was elevated in such diseased tissue. Here, MLKL is linked to pulmonary arterial hypertension.